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with advanced disease. Such testing could improve diag-
nostics, reduce false-negative results, and strengthen the 
reliability of epidemiologic data during ongoing and fu-
ture outbreaks.
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We report partial molecular characterization of isolates from 
an autochthonous chikungunya virus cluster in the Latium 
Region of Italy. E1 sequences from 3 patients differ sub-
stantially from sequences from the 2007 outbreak in Italy 
and lack the A226V substitution associated with increased 
viral fitness in the Aedes albopictus mosquito vector.
Local transmission of chikungunya virus (CHIKV) has been confirmed in the Lazio region of Italy, with 2 
related autochthonous clusters in the cities of Anzio and 
Rome (1). This event is the second known autochthonous 
outbreak of CHIKV in Italy; the previous one occurred in 
2007 in the Emilia Romagna region and included >205 
cases of CHIKV infection during July 4–Sept 27, 2007 (2). 
During the time between the 2 epidemics in Italy, autoch-
thonous transmissions were described in France in 2010, 
2014, and 2017; these events have focused attention on this 
infection because of the Aedes albopictus mosquito vector 
establishing itself in parts of the Mediterranean basin and 
beyond. Ae. albopictus mosquitoes are assumed to be the 
vector in the ongoing outbreak in Italy because Ae. aegypti 
mosquitoes are not circulating in this country. The Labora-
tory of Virology of Lazzaro Spallanzani National Institute 
for Infectious Disease (INMI) in Rome, as the regional ref-
erence laboratory for arboviral infections, is in charge of 
CHIKV diagnosis and surveillance for the Latium region. 
CHIKV diagnosis is based on the detection of the viral 
genome by real-time reverse transcription PCR (RT-PCR) 
and of virus-specific antibodies by serologic tests. We con-
ducted sequence analysis of endpoint PCR amplicons from 
selected case-patients to confirm the identity of the virus de-
tected by real-time RT-PCR and performed virus isolation 
whenever possible. The first case-patient detected at INMI, 
a resident of Anzio (60 km from Rome) with no recent trav-
el history abroad, was admitted to the Tropical Infectious 
Disease Unit on August 30, 2017, with suspected measles. 
Hospital staff suspected an arboviral disease on Septem-
ber 3, and on September 5, a serologic test was positive for 
chikungunya virus (E. Nicastri, unpub. data). The official 
notice of autochthonous cases in this region was disclosed 
on September 8, 2017. As of September 26, a total of 183 
CHIKV infections have been reported (109 confirmed and 
74 probable) (3), consistent with an extensive autochthonous 
outbreak. An intensive diagnostic campaign and backtracing 
of cases is under way to establish the extent of the outbreak.
Phylogenetic analyses of CHIKV strains obtained dur-
ing outbreaks in different geographic regions (Réunion, 
Seychelles, Mauritius, Madagascar, and Mayotte) have 
identified the independent acquisition of a common mu-
tation, A226V, in the E1 glycoprotein (4). This muta-
tion, together with mutations M269V and D284E in E1 
glycoproteins, has been described as a molecular signature of 
the Indian Ocean CHIKV outbreak (5,6). The A226V mutation 
in particular appeared in >90% of isolates after December 
2005 and has been demonstrated to increase viral fitness in Ae. 
albopictus mosquitoes, expanding the potential for CHIKV to 
diffuse (5,6). In a previous study, we described the presence of 
this mutation in CHIKV in specimens from patients referred 
to our diagnostic facility, 5 imported to Italy and 2 linked to 
the 2007 outbreak in Italy (7). In this study, we extend the ge-
netic analysis to samples from the ongoing outbreak.
We obtained a partial sequence of the E1 coding region 
directly from clinical samples of 3 patients being managed at 
INMI. These include the patient from Anzio and 2 additional 
cases belonging to a family cluster of 3 cases. On Septem-
ber 1, a 3-year-old child, born in Rome with neither travel 
history nor connection with Anzio, was brought to INMI 
with complaints of high-grade fever, arthralgia, rash, fa-
tigue, headache, and retro-orbital pain. His parents reported 
a similar febrile syndrome 24 and 48 hours later. Samples 
collected on September 6 for all 3 patients tested positive for 
CHIKV by serology and real-time RT-PCR. We obtained E1 
sequences from both parents and submitted sequences for all 
3 patients to GenBank (accession nos. MF988056–8). 
Further, we conducted a phylogenetic analysis that in-
cluded 42 available CHIKV sequences from different parts 
of the world, including sequences previously analyzed in 
our laboratory (Figure). The analysis, based on a partial E1 
sequence, showed that the virus involved in the online La-
tium region outbreak belongs to the broad group compris-
ing isolates from the East/Central/South African (ECSA) 
clade and clusters with the Indian Ocean lineage (Figure). 
This finding is similar to what was observed for the 2007 
Italy outbreak, but the current sequences are placed in a 
separate branch of the phylogenetic tree (bootstrap value 
0.83). This branch also includes recent (2016) isolates from 
Pakistan and India, suggesting a more recent origin of the 
new epidemic strain, compared with the previous one af-
fecting Italy. It is noteworthy that, unlike the isolates ob-
tained from the 2007 outbreak in the Emilia Romagna re-
gion, the E1 sequences from the ongoing outbreak lack the 
A226V mutation, as do all the recent isolates placed on the 
same branch of the phylogenetic tree. Further study will 
establish the relevance of this and other genetic signatures 
to the fitness of the virus for the local mosquito vectors and 
will determine the extent of transmission cycles in humans.
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We report a lung-invasive fungal disease with possible cu-
taneous needle tract seeding in a patient with a febrile neu-
tropenia caused by the Basidiomycetes mold Inonotus spp. 
Although rare, Inonotus spp. should be added to the list of 
microorganisms causing invasive fungal disease in neutro-
penic patients with hematologic malignancies.
A 33-year-old man in Madrid, Spain, with chronic myeloid leukemia in lymphoid blastic phase under-
went allogeneic stem cell transplantation (SCT) from a 
matched unrelated donor in 2011. Four years later, he had 
an extramedullary pulmonary relapse, after which he began 
intensive reinduction chemotherapy. After the second cycle, 
prolonged severe aplasia developed in the patient. Invasive 
fungal disease (IFD) was suspected because of the presence 
of persistent fever despite broad-spectrum antimicrobial 
drugs and the appearance of a new pulmonary nodule (Fig-
ure, panel A; online Technical Appendix, https://wwwnc.
cdc.gov/EID/article/24/1/17-1265-Techapp1.pdf) while the 
patient was receiving prophylactic micafungin (50 mg/d). 
Serologic fungal biomarkers were negative. A percutaneous 
pulmonary biopsy sample was taken, and empirical lipo-
somal amphotericin B (3 mg/kg/d) was started (December 
2015). Histology showed unspecific inflammatory tissue, 
and microbiology cultures were negative.
Salvage human leukocyte antigen–haploidentical SCT 
was performed in January 2016. Fever persisted during 
conditioning therapy, and a solitary cutaneous millimet-
ric erythematous lesion appeared at the biopsy puncture 
site (Figure, panel B). Histopathology of the skin lesion 
showed dermal infiltration by periodic acid Schiff–posi-
tive elements compatible with fungal hyaline hyphae with 
parallel walls, regular septa, and branched hyphae with oc-
casional bulb-like expansions; angioinvasion; and necrosis. 
Fungal culture of the specimen was negative, but panfungal 
PCR and further sequencing (1) revealed the presence of 
Inonotus spp. Voriconazole was added, and the lesion re-
solved in days. Neutrophil engraftment was achieved on 
day 12 post-SCT, with complete donor chimerism.
On day 34, the pulmonary lesion progressed, but we 
could not prove IFD as the cause of concomitant pleural 
effusion. Despite intensified antifungal therapy, surgical 
debridement was required to resolve the empyema. The pa-
tient was discharged on oral posaconazole (300 mg/d) that 
was eventually replaced by micafungin.
A computed tomography scan performed 6 months af-
ter the SCT showed persistence of a single mass on the left 1These authors contributed equally to this article.
